Torrent Pharmaceuticals stock

TORNTPHARM · NSE · INR

Compare Torrent Pharmaceuticals
₹4,689.50Change from previous close: +1.70%Absolute change: +₹78.50

Close · November 20, 2026

Price history

+26.01% over the period

1 year: from ₹3,721.40 (November 20, 2025) to ₹4,689.50 (November 20, 2026), +26.01%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026₹4,689.50
October 30, 2026₹4,613.40
September 30, 2026₹4,800.00
August 31, 2026₹5,066.00
July 31, 2026₹5,122.80
June 30, 2026₹4,620.10
May 29, 2026₹4,410.80
April 30, 2026₹4,185.10
March 30, 2026₹4,220.20
February 27, 2026₹4,333.30
January 30, 2026₹3,960.80
December 31, 2025₹3,850.00
November 28, 2025₹3,720.60
November 20, 2025₹3,721.40

At a glance

  • The company

    Research, develop, manufacture, market and distribute branded and generic pharmaceutical formulations across multiple therapeutic areas

  • Latest results

    Quarter to September 30, 2026 · EPS ₹14.23 (estimate ₹16.08)

TickerLandia's take on Torrent Pharmaceuticals

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low₹3,680.10
52-wk high₹5,250.00

−10.68% from the 52-week high

Analysts · 28 analysts

Average target₹5,472.79+16.70% vs. price

Buy 23 · Hold 4 · Sell 1

TickerLandia Fingerprint: Torrent Pharmaceuticals

Compared with similar companies: very low risk and very high price.

Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Torrent Pharmaceuticals is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2026), Torrent Pharmaceuticals's P/E today is 73.4, above the median of its last 10 fiscal years (47.5; between 28.1 and 75.0 from 2017 to 2026). Torrent Pharmaceuticals's P/E (trailing 12 months): 79.2, +137% against the median of a group of 11 similar companies (33.5).

P/E compared with its history

Compared with 11 similar companies

Torrent Pharmaceuticals's metrics compared with similar companies
MetricTorrent PharmaceuticalsPosition in the groupBand
P/E (trailing 12 months)79.2High
Forward P/E51.6High
Operating margin22.2%Middle
ROE15.7%Middle
Debt/equity0.77High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Torrent Pharmaceuticals. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

₹49.79B

Latest quarter · Q3 2026

Net income

₹5.34B

Latest quarter · Q3 2026

Quarterly net margin

10.7%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
₹1.78T
P/E
79.2
EPS
₹59.20
Volume
200.04K
Daily trading
€14.75M
Dividend yield
0.19%
Last ex-dividend on May 29, 2026

How Torrent Pharmaceuticals is changing

All results
  • Revenue grew 11.8% a year on average over the last 5 years

  • Operating margin rose from 22.2% to 24.6%

  • Profits turn into cash: free cash flow equal to 125% of net income

Returns

Torrent Pharmaceuticals returns with dividends

₹1,000 invested in Torrent Pharmaceuticals 5 years ago, on November 22, 2021, would be worth ₹3,617 today with dividends reinvested: +261.70% in total, +29.36% per year. On price alone it would be ₹3,407 (+240.66%).

PeriodTorrent Pharmaceuticals₹1,000 becomes
1 month+2.98%₹1,030
6 months+5.88%₹1,059
Year to date+21.81%₹1,218
1 year+27.14%₹1,271
3 years+128.75%₹2,288
5 years+261.70%₹3,617
10 years+710.86%₹8,109

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Torrent Pharmaceuticals: technical analysis

Torrent Pharmaceuticals shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 8.5% below its all-time closing high (₹5,122.80, July 31, 2026).

Trend
No clear trend
RSI (14 sessions)
51
Between 30 and 70
vs 200-session average
+2.42%

Support and resistance

Price areas where Torrent Pharmaceuticals has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance₹5,051.57+7.72%4 touches, last on September 24, 2026
  2. Resistance₹4,830.44+3.01%5 touches, last on November 9, 2026
  3. Resistance₹4,691.33+0.04%3 touches, last on July 17, 2026
  4. Last price₹4,689.50
  5. Support₹4,473.23−4.61%3 touches, last on October 26, 2026
  6. Support₹4,246.43−9.45%3 touches, last on June 2, 2026
  7. Support₹4,095.30−12.67%4 touches, last on April 23, 2026

Volatility and risk

Volatility (60 sessions, annualised)
18.4%
Largest fall in the last year
−11.68%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Torrent Pharmaceuticals: seasonality

Average monthly price change over 32 years

−0.1%Jan−0.2%Feb−1.0%Mar+1.9%Apr+1.8%May+1.9%Jun+6.3%Jul+7.4%Aug+0.7%Sep−0.3%Oct+2.5%Nov+5.4%Dec

Over the last 32 years, the strongest month for Torrent Pharmaceuticals has been August: +7.42% on average, positive in 19 years out of 32. The weakest has been March: −1.04% on average, positive in 16 years out of 32. November, the current month, has been positive in 20 years out of 31 (+2.48% on average).

Show chart data
MonthAverageMedianPositive years
January−0.06%−2.28%13 of 32
February−0.22%−1.02%12 of 32
March−1.04%−1.04%16 of 32
April+1.90%+3.59%21 of 32
May+1.78%+0.56%18 of 32
June+1.88%+2.08%20 of 32
July+6.32%+7.44%27 of 32
August+7.42%+1.28%19 of 32
September+0.71%−1.47%13 of 32
October−0.31%+1.05%17 of 32
November+2.48%+1.88%20 of 31
December+5.40%+5.55%24 of 32

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Torrent Pharmaceuticals and its competitors

Shelcal, Tedibar, Unienzyme, ProZuca and Ahaglow are among the brands under which the company sells its products. Torrent Pharmaceuticals develops, makes, markets and distributes branded and generic medicines, along with vitamin, mineral and nutrient supplements. Its range spans diabetes, cardiovascular care, the central nervous system, oncology, gastrointestinal, urology and dermatology treatments, among others. The company also offers contract manufacturing services and sells in India, the United States, Brazil, Germany, Malta and other international markets.

Headquarters
Ahmedabad, India
Employees
18,258
Founded
1959
Chief executive
Aman Mehta
Torrent Pharmaceuticals and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Torrent PharmaceuticalsTORNTPHARM$19.25B22.2%79.2+5.88%
Shionogi4507$16.75B31.6%11.2+2.83%
PharmaEssentia6446$15.94B38.4%74.1+54.65%
Hansoh Pharmaceutical Group3692$23.77B37.3%25.0−8.51%
Yunnan Baiyao Group000538$15.07B11.2%19.4+11.07%
Laurus LabsLAURUSLABS$14.13B24.1%97.8+68.58%

Same industry or related industries, similar size. Compare Torrent Pharmaceuticals with its competitors · Full profile